IMUX Chart
- 52-Week Range: $5.15 - $14.77
- Market Capitalization: $198.82M
- Short Percentage: 0%
- Target Price: $50.50
- Shares Outstanding: 30.54M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
IMUX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Immunic Inc. (IMUX) CEO Daniel Vitt on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 10th
- Immunic, Inc. to Participate in Upcoming Investor and Industry ConferencesPRNewsWire | April 25th
- Immunic, Inc. Announces Promotion of Glenn Whaley, CPA to Chief Financial OfficerPRNewsWire | March 16th
- Immunic, Inc. to Participate in Investor and Scientific Conferences in MarchPRNewsWire | March 8th
- Immunic Inc. (IMUX) CEO Daniel Vitt on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 24th
- Immunic, Inc. Reports Year End 2021 Financial Results and Highlights Recent ActivityPRNewsWire | February 24th
- Immunic, Inc. to Participate in Investor and Scientific Conferences in FebruaryPRNewsWire | February 8th
Company Info
Website: https://www.immunic-therapeutics.com
Address: 1200 Avenue of the Americas, New York, NY, United States, 10036
Sector: Healthcare
Industry: Biotechnology
Full time employees: 55
Address: 1200 Avenue of the Americas, New York, NY, United States, 10036
Sector: Healthcare
Industry: Biotechnology
Full time employees: 55
$IMUX I REALLY THINK WE FINALLY HAVE OUR FIRESALE?? !!
$IMUX how long until we take off?
$IMUX must buyyy
$IMUX CHUG CHUG CHUG
$IMUX Let’s get it
$IMUX I hope I never have to work for anyone again after this
$IMUX She's gettin' ready to...
$IMUX what happens?
$IMUX I’m selling y’all have fun bag holding